News | November 13, 2021
Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Biocon Biologics and Viatris co-developed the products
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Second interchangeable biosimilar product approved by agency
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
Investment of Rs 235 crores to add 411 beds in the next 18 months
The company is eligible for 12 months exclusivity from launch
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
Subscribe To Our Newsletter & Stay Updated
